Podcast Episodes
Back to SearchCan increased physical activity after adjuvant therapy for colon cancer improve disease-free survival?
Episode 514
The CHALLENGE trial at ASCO 2025 showed that increased physical activity improves survival rates in colon cancer patients, with the exercise group de…
1 year, 2 months ago
Evolving CLL Therapy: The Power of Doublet and Triplet Regimens
Episode 513
John N. Allan, MD and Andrew H. Lipsky, MD discuss the evolution of CLL therapy and the power of doublet and triplet regimens, exploring combinations…
1 year, 2 months ago
Safety of Treatments for HER2-Mutant Lung Cancer
Episode 512
Drs. Scott and Liu discuss the safety of treatments for HER2-mutant lung cancer, including key toxicities, management strategies, and how prior thera…
1 year, 2 months ago
Advances in Treating HER2-Mutant Lung Cancer: Efficacy
Episode 511
Stephen V. Liu, MD and Susan C. Scott, MD discuss advances in treating HER2-mutant lung cancer. Until recently, treatments for HER2-mutant lung cance…
1 year, 2 months ago
What's fueling the rapid rise of measles in North America despite vaccine availability?
Episode 510
Measles cases in North America have exceeded 3,200, mainly due to low vaccination rates, with children most affected. Clinicians are urged to verify …
1 year, 2 months ago
Could a new rescue inhaler strategy reduce severe asthma attacks in mild cases?
Episode 509
This week's episode covers the effectiveness of a fixed-dose albuterol-budesonide combination for asthma, new findings on Nerodomelast for progressiv…
1 year, 2 months ago
Could ending PEPFAR lead to 1 million new pediatric HIV cases by 2030?
Episode 508
A Lancet study warns of consequences for HIV prevention if PEPFAR loses funding, potentially millions of new pediatric HIV cases and increased AIDS-r…
1 year, 2 months ago
Revisiting Anemia Response in Myelofibrosis: Revised International Working Group Criteria
Episode 507
Drs. Pemmaraju and Bose discuss the revised International Working Group criteria for anemia response in patients with myelofibrosis, outlining new de…
1 year, 3 months ago
Leukemic Transformation in Myelofibrosis: Risks, Realities, and Evolving Strategies
Episode 506
Drs. Bose and Pemmaraju discuss leukemic transformation in patients with myelofibrosis, reviewing its incidence, as well as risk factors, treatment, …
1 year, 3 months ago
Understanding Secondary Myelofibrosis: Diagnosis, Treatment, and Prognosis
Episode 505
Drs. Bose and Pemmaraju review secondary myelofibrosis arising from polycythemia vera or essential thrombocythemia and how it differs from primary my…
1 year, 3 months ago